138 related articles for article (PubMed ID: 23232925)
1. BODIPY-phosphane as a versatile tool for easy access to new metal-based theranostics.
Tasan S; Zava O; Bertrand B; Bernhard C; Goze C; Picquet M; Le Gendre P; Harvey P; Denat F; Casini A; Bodio E
Dalton Trans; 2013 May; 42(17):6102-9. PubMed ID: 23232925
[TBL] [Abstract][Full Text] [Related]
2. Self-Assembly of Novel Thiophene-Based BODIPY Ru
Gupta G; Das A; Panja S; Ryu JY; Lee J; Mandal N; Lee CY
Chemistry; 2017 Dec; 23(68):17199-17203. PubMed ID: 28961334
[TBL] [Abstract][Full Text] [Related]
3. Ruthenium(II) and osmium(II) 1,2,3-triazolylidene organometallics: a preliminary investigation into the biological activity of 'click' carbene complexes.
Kilpin KJ; Crot S; Riedel T; Kitchen JA; Dyson PJ
Dalton Trans; 2014 Jan; 43(3):1443-8. PubMed ID: 24201979
[TBL] [Abstract][Full Text] [Related]
4. Gold(i)-BODIPY-imidazole bimetallic complexes as new potential anti-inflammatory and anticancer trackable agents.
Trommenschlager A; Chotard F; Bertrand B; Amor S; Dondaine L; Picquet M; Richard P; Bettaïeb A; Le Gendre P; Paul C; Goze C; Bodio E
Dalton Trans; 2017 Jun; 46(25):8051-8056. PubMed ID: 28594007
[TBL] [Abstract][Full Text] [Related]
5. Towards the elaboration of new gold-based optical theranostics.
Doulain PE; Decréau R; Racoeur C; Goncalves V; Dubrez L; Bettaieb A; Le Gendre P; Denat F; Paul C; Goze C; Bodio E
Dalton Trans; 2015 Mar; 44(11):4874-83. PubMed ID: 25492395
[TBL] [Abstract][Full Text] [Related]
6. Novel heterobimetallic radiotheranostic: preparation, activity, and biodistribution.
Adriaenssens L; Liu Q; Chaux-Picquet F; Tasan S; Picquet M; Denat F; Le Gendre P; Marques F; Fernandes C; Mendes F; Gano L; Campello MP; Bodio E
ChemMedChem; 2014 Jul; 9(7):1567-73. PubMed ID: 24449620
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Localization of Highly Fluorescent and Photostable BODIPY-Based Ruthenium(II), Rhodium(III), and Iridium(III) Metal Complexes.
Gupta G; Kumari P; Ryu JY; Lee J; Mobin SM; Lee CY
Inorg Chem; 2019 Jul; 58(13):8587-8595. PubMed ID: 31117633
[TBL] [Abstract][Full Text] [Related]
8. Organometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicity.
Kandioller W; Balsano E; Meier SM; Jungwirth U; Göschl S; Roller A; Jakupec MA; Berger W; Keppler BK; Hartinger CG
Chem Commun (Camb); 2013 Apr; 49(32):3348-50. PubMed ID: 23505633
[TBL] [Abstract][Full Text] [Related]
9. High coating of Ru(II) complexes on gold nanoparticles for single particle luminescence imaging in cells.
Rogers NJ; Claire S; Harris RM; Farabi S; Zikeli G; Styles IB; Hodges NJ; Pikramenou Z
Chem Commun (Camb); 2014 Jan; 50(5):617-9. PubMed ID: 24281162
[TBL] [Abstract][Full Text] [Related]
10. Gold(I) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents.
Serebryanskaya TV; Lyakhov AS; Ivashkevich LS; Schur J; Frias C; Prokop A; Ott I
Dalton Trans; 2015 Jan; 44(3):1161-9. PubMed ID: 25413270
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic gold(I) N-heterocyclic carbene complexes with phosphane ligands as potent enzyme inhibitors.
Rubbiani R; Salassa L; de Almeida A; Casini A; Ott I
ChemMedChem; 2014 Jun; 9(6):1205-10. PubMed ID: 24677779
[TBL] [Abstract][Full Text] [Related]
12. Alkynyl gold(I) phosphane complexes: Evaluation of structure-activity-relationships for the phosphane ligands, effects on key signaling proteins and preliminary in-vivo studies with a nanoformulated complex.
Andermark V; Göke K; Kokoschka M; Abu El Maaty MA; Lum CT; Zou T; Sun RW; Aguiló E; Oehninger L; Rodríguez L; Bunjes H; Wölfl S; Che CM; Ott I
J Inorg Biochem; 2016 Jul; 160():140-8. PubMed ID: 26850306
[TBL] [Abstract][Full Text] [Related]
13. Highly luminescent metallacages featuring bispyridyl ligands functionalised with BODIPY for imaging in cancer cells.
Woods B; Döllerer D; Aikman B; Wenzel MN; Sayers EJ; Kühn FE; Jones AT; Casini A
J Inorg Biochem; 2019 Oct; 199():110781. PubMed ID: 31357067
[TBL] [Abstract][Full Text] [Related]
14. Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.
Hanif M; Nazarov AA; Hartinger CG; Kandioller W; Jakupec MA; Arion VB; Dyson PJ; Keppler BK
Dalton Trans; 2010 Aug; 39(31):7345-52. PubMed ID: 20601976
[TBL] [Abstract][Full Text] [Related]
15. Double-Strand DNA Breaks Induced by Paracyclophane Gold(I) Complexes.
Bestgen S; Seidl C; Wiesner T; Zimmer A; Falk M; Köberle B; Austeri M; Paradies J; Bräse S; Schepers U; Roesky PW
Chemistry; 2017 May; 23(26):6315-6322. PubMed ID: 28156042
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structure and spectral and electrochemical properties of 3-pyrrolyl BODIPY-metal dipyrrin complexes.
Lakshmi V; Lee WZ; Ravikanth M
Dalton Trans; 2014 Nov; 43(42):16006-14. PubMed ID: 25232656
[TBL] [Abstract][Full Text] [Related]
17. Thiolato gold(I) complexes containing water-soluble phosphane ligands: a characterization of their chemical and biological properties.
Vergara E; Cerrada E; Clavel C; Casini A; Laguna M
Dalton Trans; 2011 Nov; 40(41):10927-35. PubMed ID: 21904768
[TBL] [Abstract][Full Text] [Related]
18. Polynuclear ruthenium, osmium and gold complexes. The quest for innovative anticancer chemotherapeutics.
Hartinger CG; Phillips AD; Nazarov AA
Curr Top Med Chem; 2011; 11(21):2688-702. PubMed ID: 22039871
[TBL] [Abstract][Full Text] [Related]
19. BR2BodPR2: highly fluorescent alternatives to PPh3 and PhPCy2.
Davies LH; Harrington RW; Clegg W; Higham LJ
Dalton Trans; 2014 Sep; 43(36):13485-99. PubMed ID: 24954582
[TBL] [Abstract][Full Text] [Related]
20. Gold-phosphine-porphyrin as potential metal-based theranostics.
Tasan S; Licona C; Doulain PE; Michelin C; Gros CP; Le Gendre P; Harvey PD; Paul C; Gaiddon C; Bodio E
J Biol Inorg Chem; 2015 Jan; 20(1):143-154. PubMed ID: 25476859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
